Article and Video CATEGORIES

Cancer Journey

Search By

Denise Brock

Denise has over 30 years of varying experience in the healthcare arena.  In August 2009 she joined The Global Resource for Advancing Cancer Education as one of its first employees.  She has grown with the organization and now oversees the operational movement of programs, efficiency, and effectiveness within the organization, as well as the daily processes and functions.  


Registration is available for the 2022 English and Spanish Targeted Therapies Patient Forums!
Denise Brock
2022 Targeted Therapies Patient Forum

Join us on SATURDAY, JULY 16th, 2022, for the 2022 Targeted Therapies Patient Forum

This virtual program is presented Live Online from 10 AM - 4 PM EST

Register Now! 

In this 8th annual live patient forum, leading thoracic oncologists from around the world as well as lung cancer patients who are active within the patient advocacy community discuss subjects relevant to all targets as well as breakout sessions on rare mutations.


This 6-hour live virtual webinar is an opportunity for lung cancer patients and caregivers to hear from experts and participate in live virtual question and answer sessions.  The forum offers panel discussions, live Q&A sessions, and breakout sessions focused on rare mutations such as EGFR, ALK, ROS, RET and KRAS.  This event is free but registration is required and limited.  For more information visit the AGENDA and the FACULTY.


Foro de Pacientes de Terapias Dirigidas en Español!

Únase a nosotros el SÁBADO, 30 de julio de 2022, 09:00 a. m., hora del este.

Este programa virtual se presenta en vivo en línea a partir de las 9 a. m. EST.

Regístrate Ahora

Únase a nosotros para el segundo Foro Anual de Pacientes de Terapias Dirigidas. Este evento virtual en vivo está diseñado específicamente para la comunidad de cáncer de pulmón de habla hispana. El evento de medio día invitará a los asistentes a enviar preguntas en tiempo real, creando una conversación con los pacientes durante este evento virtual en vivo y abordando las preocupaciones específicas de la comunidad de habla hispana.


Este seminario web virtual en vivo de 2 horas es una oportunidad para que los pacientes con cáncer de pulmón y los cuidadores en la comunidad de cáncer de pulmón de habla hispana escuchen a profesores expertos de los Estados Unidos, Colombia y Costa Rica. El evento ofrece paneles de discusión y sesiones de preguntas y respuestas en vivo que cubren la terapia dirigida general, así como mutaciones como EGFR, ALK y otras. Este evento es gratuito, pero el registro es obligatorio y limitado. La agenda completa estará disponible pronto.

Para más información visita la Agenda y la Facultad

Registration for the Spanish Targeted Therapies Patient Forum is now open! Join us on SATURDAY,

Jul 30, 2022, 09:00 AM Eastern Time,  This virtual program is presented Live Online starting at 9 AM EST.
Join us for the 2nd Annual Targeted Therapies Patient Forum.  This live virtual event is specifically designed for the Spanish-speaking lung cancer community. The half-day event will engage attendees to submit questions in real time, creating a conversation with patients during this live virtual event and addressing the specific concerns of the Spanish-speaking community. 

This 2-hour live virtual webinar is an opportunity for lung cancer patients and caregivers in the Spanish speaking lung cancer community to hear from expert faculty from the United States, Columbia and Costa Rica.  The event offers panel discussions and live Q&A sessions covering general targeted therapy as well as mutations such as EGFR, ALK and others.  This event is free but registration is required and limited.  The full agenda willl be available soon.  
More information will be available soon! 


2022 Spanish TTF header
Video Language

Next Previous link

Previous PostNext Post

Related Content

Lung Cancer OncTalk 2023
At our live event, Lung Cancer OncTalk 2023, Dr. Yang, Das, and Dagogo-Jack discuss commonly used terms in treatment options for lung cancer, how oncologists determine the stage of lung cancer, and what that means for treatment, the importance of driver mutation in NSCLC treatment, the vast number of NSCLC trials, among other topics which involve lung cancer treatments. To watch the complete playlist click here.
Lung Cancer OncTalk 2023
At our live event, Lung Cancer OncTalk 2023, Dr. Jeff Yang, discusses different surgical procedures used to treat early-stage lung cancer and different approaches to removing cancerous tissue from the lung. 
Lung Cancer OncTalk 2023
At our live event, Lung Cancer OncTalk 2023, Dr. Millie Das, discusses different Studies and Trials for NSCLC. Dr. Das specializes in the treatment of thoracic malignancies. She sees and treats patients both at the Stanford Cancer Center and at the Palo Alto VA Hospital. She is the Chief of Oncology at the Palo Alto VA and is an active member of the VA National Lung Cancer Working Group and Lung Cancer Precision Oncology Program. Learn more about Dr. Das here.

Forum Discussions

Hi and welcome to Grace.  Wow, I don't know why you can't get in to see your doc but I'd find a way or find another doc who can walk you...

Hi Amber, Welcome to Grace.  I'm so sorry you're going through this scare.  It could be a recurrence.  It also is as likely to be the contrast creating a better view. ...

Hi Blaze,


As much as I hate to say it, Welcome back Blaze.  It sounds like you're otherwise feeling good and enjoying life which is a wonderful place to be. ...

Waiting for my appointment with oncologist this morning. Thank you for the response. It helps. <3

It sounds like you’re thinking of this in a very appropriate way. Specifically, it sounds like the growth of the nodule is rather modest, though keep in mind that the change...

Hi and welcome to GRACE.  I'm sorry your mom is having this difficulty.  An indwelling catheter is used when the pleura space continually fills and the catheter is always there to...

Recent Comments

Joanne indwelling catheters
By arm2966 on
Hi and welcome to Grace. …
By JanineT GRACE … on
Hi Amber, Welcome to Grace. …
By JanineT GRACE … on
Could you
By Maeve785 on